Drug intelligence / Profile preview

tiaoying zengye decoction

Development stage: Unknown
Lead developer: Shanghai Jing'an Mental Health Center
Administration: Oral

Overview

Tiaoying Zengye Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Shanghai Jing'an Mental Health Center for the treatment of clozapine-induced constipation. Clozapine, an atypical antipsychotic, frequently causes gastrointestinal hypomotility and severe constipation due to its potent anticholinergic and antiserotonergic properties. Tiaoying Zengye Decoction is designed to increase fluids (Zengye) and regulate the nutritive level (Tiaoying), aiming to moisten the intestines and promote bowel movements. It is currently being evaluated in clinical trials to determine its efficacy and safety as a complementary therapy for psychiatric patients experiencing treatment-resistant constipation.

Other names: Tiaoying Zengye TangTiaoying Zengye Decoction

Beyond the preview

Go deeper on tiaoying zengye decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tiaoying zengye decoction.

Explore the full profile